Obesity Drugs Enjoy a Much-Needed Winning Streak
Bloomberg Businessweek
Introduction
Discussion on a recent study by Novo Nordisk on weight loss drug WeGoV, its impact on cardiovascular disease, and positive developments in the field of weight loss drugs.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
